Role of radiotherapy in recurrent gliomas;Récidives dans les tumeurs gliales: Place de la radiothérapie

Bulletin du Cancer

Volumn 91, Issue 11, 2004, Pages 883-889

  Dhermain, Frédéric ^a   De Crevoisier, Renaud ^a   Parker, Fabrice ^b   Cioloca, Cornelius ^c   Kaliski, Alexandre ^a   Beaudre, Anne ^a   Lefkopoulos, Dimitri ^a   Armand, Jean Pierre ^a   Haie Meder, Christine ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b BICÊTRE HOSPITAL   (France)

^c Service de Neurochirurgie   (France)

Author keywords

Intracranial glioma; Primary brain tumor; Radiosurgery; Re irradiation; Recurrent glioma; Stereotactic radiotherapy

Indexed keywords

LOMUSTINE; PROCARBAZINE; VINCRISTINE;

BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COGNITION; DISEASE COURSE; DISEASE DURATION; FOLLOW UP; GLIOMA; HEALTH STATUS; HISTOLOGY; HOSPITAL BED; HUMAN; INTERMETHOD COMPARISON; MEDICAL DOCUMENTATION; NEUROLOGICAL COMPLICATION; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIOMA; PATIENT SELECTION; PROGNOSIS; QUALITY OF LIFE; RADIATION DOSE; RADIATION INJURY; REOPERATION; REVIEW; SPINAL CORD; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; SYMPTOM; TUMOR VOLUME;

AGE FACTORS; BRAIN NEOPLASMS; GLIOMA; HUMANS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REOPERATION; RISK ASSESSMENT;

EID: 11244254261     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Philippon J. Tumeurs cérébrales : du diagnostic au traitement. Paris : Masson, 2004.
2. Frappaz D, le groupe de travail SOR. Standards, Options et Recommandations 2002 pour la prise en charge des patients atteints de gliomes intracrâniens de l'adulte (rapport abrégé). Bull Cancer 2003 ; 90 : 873-86.
3. Kleihues P, Cavenee WK. Pathology and genetics of tumours of the nervous system. Lyon : ARC Press, 2000.
4. Walker MD, Green SB, Byar DP, Alexander Jr E, Batzdorf U, Brooks WH, et al. Randomized comparisons of radiotherapy for the treatment of malignant glioma after surgery. N Engl J Med 1980 ; 303 : 1323-9.
5. Roa W, Brasher PM, Bauman G, Anthes M, Bruera E, Chan A, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme : a prospective randomized clinical trial. J Clin Oncol 2004 ; 22 : 1583-8.
6. Karim ABMF, Maat B, Hatlevoll R, Menten J, Rutten EH, Thomas DG, et al. A randomized trial on dose response in radiation therapy of low-grade cerebral glioma : European Organization for Research and Treatment of Cancer (EORTC) study 22844. Int J Radiat Oncol Biol Phys 1996 ; 36 : 549-56.
7. Wong ET, Hess KR, Gleason MJ. Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials. J Clin Oncol 1999 ; 17 : 2572-8.
8. Nieder C, Grosu AL, Molls M. A comparison of treatment results for recurrent malignant gliomas. Cancer Treat Rev 2000 ; 26 : 397-409.
9. Tatter SB. Recurrent malignant glioma in adults. Curr Treat Options Oncol 2002 ; 3 : 509-24.
10. Chan JL, Lee SW, Fraas B. Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 2002 ; 20 : 1635-42.
11. Milker-Zabel S, Zabel A, Thilmann C, Zuna I, Hoess A, Wannenmacher M, et al. Results of three-dimensional stereotactically-guided radiotherapy in recurrent medulloblastoma. J Neuro-Oncol 2002 ; 60 : 227-33.
12. Jeackle KA, Hess KR, Yung WK, Greenberg H, Fine H, Schiff D, et al. Phase II trial of remozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma : a North American Brain Tumor Consortium study. J Clin Oncol 2003 ; 21 : 2305-11.
13. Sheperd SF, Laing RW, Cosgrove VP, Warrington AP, Hines F, Ashley SE, et al. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys 1997 ; 37 : 393-8.
14. Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 1999 ; 45 : 1133-41.
15. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases : final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys 2000 ; 47 : 291-8.
16. Kim HK, Thornton AF, Greenberg HS, Page MA, Junck L, Sandler HM. Results of re-irradiation of primary intracranial neoplasms with three-dimensional conformal therapy. Am J Clin Oncol 1997 ; 20 : 358-63.
17. Veninga T, Langendijk HA, Slotman BJ, Rutten EH, Van der Kogel AJ, Ptick MJ, et al. Reirradiation of primary brain tumours : survival, clinical response and prognostic factors. Radiother Oncol 2001 ; 59 : 127-37.
18. Hudes RS, Corn BW, Wernet-Wasik M, Andrews D, Rosenstock J, Thoron L, et al. A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma. Int J Radiat Oncol Biol Phys 1999 ; 43 : 293-8.
19. Mergen E, Grosu A, Nieder C, Tham R, Molls M. Hypofractionated stereotactic re-irradiation of recurrent high-grade gliomas guided by aminoacids PET (SPECT)/MRI/CT Image Fusion. Proc ASTRO 2003 ; 57 (suppl. S376) ; : abstr. 2056.
20. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodgradable polymers of chemotherapy for recurrent gliomas. Lancet 1995 ; 345 : 1008-12.
21. Westphal M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, et al. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncol 2003 ; 5 : 79-88.
22. Yung WK, Albright RE, Olson J. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer 2000 ; 83 : 588-93.
23. Van den Bent MJ, Chinot O, Boogerd W, Marques JB, Taphoorn MJ, Kros JM, et al. Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV chemotherapy : EORTC Brain Tumor Group phase II study 26972. Ann Oncol 2003 ; 14 : 599-602.
24. Grill J, Renaux VK, Bulreau C, Viguier D, Levy-Piedbois C, Sainte-Rose C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 1999 ; 45 : 137-45.
25. Walker MD, Strike TA, Sheline GE. An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys 1979 ; 5 : 1725-31.
26. Crossen JR, Garwood D, Glatstein E, Neuwelt EA. Neurobehavioral sequalae of cranial irradiation in adults : a review of radiation-induced encephalopathy. J Clin Oncol 1994 ; 12 : 627-42.
27. Johannesen TB, Lien HH, Hole KH, Lote K. Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy. Radiother Oncol 2003 ; 69 : 169-76.
28. Marks JE, Baglan RJ, Prassad SC. Cerebral radionecrosis incidence and risk in relation to dose, time, fractionation, and volume. Int J Radiat Oncol Biol Phys 1981 ; 7 : 243-52.
29. Schultheiss TE, Kun LE, Ang KK, Stephens LC. Radiation response of the central nervous system. Int J Radiat Oncol Biol Phys 1995 ; 31 : 1093-112.
30. Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoencephalopathy. N Engl J Med 2001 ; 345 : 425-32.
31. Klein M, Heimans JJ, Aaronson NK, Van der Ploeg HM, Grit J, Muller M, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 2002 ; 360 : 1361-8.
32. Brown PD, Buckner JC, O'Fallon JR, Iturria NL, Brown CA, O'Neill B, et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental Stare Examination. J Clin Oncol 2003 ; 21 : 2519-24.
33. Ang KK, Price RE, Stephens LC. The tolerance of primate spinal cord to re-irradiation. Int J Radiat Oncol Biol Phys 1993 ; 25 : 459-64.
34. Wong CS, Hao Y. Long-term recovery kinetics of radiation damage in rar spinal cord. Int J Radiat Oncol Biol Phys 1997 ; 37 : 171-9.
35. Leibel SA, Gutin PH, Wara WM. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 1989 ; 17 : 1129-39.
36. Boisserie G, Cornu P, Dormont D, Sahel M, Hardiman C, Tep B, et al. Iridium 192 brachytherapy of supra-tentorial high grade glioma recurring in irradiated : technique and preliminary results of the Pitie-Salpetriere hospital group. Bull Cancer Radiother 1996 ; 83 : 144-52.
37. Halligan JB, Stelzer KJ, Rostomily RC. Operation and permanent low activity 125-I brachytherapy for recurrent high-grade astrocytomas. Int J Radiat Oncol Biol Phys 2000 ; 47 : 291-8.
38. Simon JM, Cornu P, Boisserie G. Brachytherapy of glioblastoma recurring in previously irradiated territory : predictive value of tumor volume. Int J Radiat Oncol Biol Phys 2002 ; 53 : 67-74.
39. Arcicasa M, Roncadin M, Bidoli E, Dedkov A, Gigante M, Trovo MG. Reirradiation and lomustine in patients with relapsed high-grade gliomas. Int J Radiat Oncol Biol Phys 1999 ; 43 : 789-93.
40. Voynov G, Kaufman S, Hong T, Pinkerton A, Simon R, Dowsett R. Treatment of recurrent malignant gliomas with stereotactic intensity modulated radiation therapy. Am J Clin Oncol 2002 ; 25 : 606-11.
41. Haie-Meder C, Beaudré A, Breton C, Biron B, Cordova A, Dubray B, et al. La radiothérapie conformationnelle des tumeurs cérébrales. Cancer Radiother 1999 ; 3 : 407-13.
42. Shrieve DC, Alexander E, Wen PY. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 1995 ; 36 : 275-84.
43. Shibamoto Y, Yamashita J, Takahashi M, Abe M. Intraoperative radiation therapy for brain tumors with emphasis on retreatment for recurrence following full-dose external beam irradiation. Am J Clin Oncol 1994 ; 17 : 396-9.
44. Choucair AK, Scott C, Urtasun R, Nelson D, Mousas B, Curran W. Quality of life and neuropsychological evaluation for patients with malignant astrocytomas : RTOG 91-14. Int J Radiat Oncol Biol Phys 1997 ; 38 : 9-20.